Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
NYU's Ambulatory Care Center at 240 East 38th Street, New York
will be on Wednesday, March 9, at 6:30-8:00 PM, on the 11th floor of NYU's Ambulatory Care Center at 240 East 38th Street, between 2nd and 3rd Avenues.
We are excited to have have guest speaker Dr. Jennifer Wolkin attend this meeting, who will discuss mindfulness and meditation in relation to vitiligo. Our resident experts, Dr. Nada Elbuluk and Dr. Beth McLellan will be present and answer questions. There will also be a brief presentation on research updates in vitiligo.
Please let us know if you will be able to attend by email email@example.com.
We look forward to seeing everyone there!
Like us on Facebook for updates and interesting articles at: facebook.com/nyvitiligo
- What are risks of oral and topical corticosteroids?
Corticosteroid drugs (like hydrocortisone, and others) are often used for treating vitiligo. By mimicing the effects of hormones your body produces naturally in your adrenal gla...
- Vitiligo and hearing loss: any connection?
In short, NO. Recent research shows no relationship between a degree of skin depigmentation and hearing loss severity in vitiligo patients. The results of this study showed tha...
- Is it possible to stop the progression of vitiligo?
It is true that vitiligo progression could be stopped in 4 out of 5 cases by the use of potent systemic corticosteroids - that is, oral medications. However, systemic corticost...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.